Fulvestrant

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Fulvestrant has been used: as an antagonist of estrogen receptor (ER&#945 and ER &#946 ) to reduce hepatocytes proliferation as an antagonist of ER for the suppression of estrogen responsive element in human breast cancer MCF-7 cells